Introdução
O que você precisa saber de cara
A cocaína é um alcaloide tropânico e estimulante do sistema nervoso central, derivado principalmente das folhas de duas espécies de coca nativas da América do Sul: Erythroxylum coca e E. novogranatense. As folhas são processadas em pasta de coca, uma mistura bruta de alcaloides da coca, da qual a base de cocaína é isolada e, então, convertida em cloridrato de cocaína. Embora a síntese total seja possível, ela é complexa e não é utilizada para produção. Historicamente, a cocaína foi um medicamento tópico padrão usado como anestésico local com propriedades vasoconstritoras intrínsecas. No entanto, seu alto potencial de abuso, efeitos adversos e custo limitaram seu uso médico e levaram à sua substituição por medicamentos alternativos.
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Nenhum gene associado encontrado
Os dados genéticos desta condição ainda estão sendo catalogados.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Síndrome de disfunção combinada hiperativa dos nervos cranianos
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Pesquisa e ensaios clínicos
Nenhum ensaio clínico registrado para esta condição.
Publicações mais relevantes
Concomitant trigeminal and glossopharyngeal neuralgia: Illustrative case and scoping review.
Cranial neuralgias are characterized by sharp lancinating pain that occurs on specific regions served by cranial nerves. Glossopharyngeal neuralgia (GPN) and trigeminal neuralgia (TN) are disorders for which etiology, epidemiology, and pain regions differ. On the other hand, the treatment stays the same as microvascular decompression, which serves as a safe approach for these entities. We performed a specific search strategy using the following Boolean terms: (Combined hyperactive dysfunction syndrome) OR ("Trigeminal" AND "Glossopharyngeal" AND "neuralgia") AND ("Concomitant" OR "Combined" OR "Simultaneous" OR "Concurrent" OR "at once" OR synchronously"). Including PubMed and Scopus, we found 73 results, of which 10 were included in the study. Furthermore, we did a manual search for one relevant study. The studies were included only if cases with concomitant TN and GPN were present. Fifteen cases were retrieved. The mean age of presentation was 66. About 53.3% of cases were left-sided; the most common etiology was posterior inferior cerebellar artery compression (73.3%). Microvascular decompression is this pathology's most popular management approach (73.3%). Only two cases reported complications (13.3%). The concomitant appearance of TN and GPN is scarce. The microvascular decompression persists as the most popular approach. There are a few treatment modalities used apart from surgical decompression. More research on these areas should be done to generate interest in their application.
Comparison of Prognosis After Microvascular Decompression in Combined and Single Hyperactive Dysfunction Syndrome of the Cranial Nerves.
Hyperactive dysfunction syndrome (HDS) of cranial nerves is caused by vascular compression of the cranial nerves and results in manifestation of specific symptoms of the involved cranial nerves. The purpose of this study was to compare the prognosis of combined and single HDS after microvascular decompression (MVD) surgery and to identify the contributing factors. From January 2001 to December 2022, a total of 5034 patients with HDS underwent 5055 MVD surgeries, of which 45 patients with combined HDS underwent 66 surgeries. Data concerning the subjects' demographic and disease-related characteristics and postoperative prognosis were collected by reviewing electronic medical records. Combined HDS had metachronous onset in 86.7% of patients and bilateral involvement in 66.7%. Hemifacial spasm (HFS) followed by trigeminal neuralgia (TN) was the most common type of combined HDS (28.9%). No significant differences were observed in postoperative prognosis between combined and single HDS for HFS, TN, and glossopharyngeal neuralgia. In combined HDS, no differences were observed in postoperative prognosis according to sex, age at surgery, symptom duration, comorbidities, and offending vessels for both HFS and TN. No significant differences in postoperative complications were identified between combined and single HDS. The prognosis after MVD surgery for combined HDS was similar to that for single HDS. MVD can be recommended as a safe and effective treatment option for patients with combined as well as single HDS.
A New Form of Combined Hyperactive Dysfunction Syndrome: A Unique Case.
Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage. There are different types of pain. Neuropathic pain is caused by a lesion or pathological condition of the somatosensory nervous system. One of the most well-known neuropathic pains is trigeminal neuralgia (TN). However, occipital neuralgia (ON) and glossopharyngeal neuralgia (GPN) exist. These three rare pathologies occur in a very small part of the global population. Combined hyperactive dysfunction syndrome is a rare disorder characterized by overactivity in different cranial nerves, TN, hemifacial spasm, and GPN. In this paper, we present a very rare case of a young woman affected by an association of overactivity in the trigeminal, occipital, and glossopharyngeal nerves, leading to TN, ON, and GPN simultaneously.
Glossopharyngeal neuralgia as initial symptom in combined hyperactive dysfunction syndrome: case report.
Hyperactive dysfunction syndrome (HDS) is defined as symptoms arising from overactivities in cranial nerves, like trigeminal neuralgia (TN), hemifacial spasm (HFS), and glossopharyngeal neuralgia (GPN). A combination of these cranial nerve neuralgias, that might or might not occur in one or both sides, either synchronously, or metachronously is called combined hyperactive dysfunction syndrome (CHDS). We presented a 73 years-old male patient with CHDS presenting with GPN as the initial symptom, with total relief from GPN, TN, and HFS after microvascular decompression. Up to date, only nine patients have been reported in the literature with symptomatic. TN-HFS-GPN. Our case is the first case with GPN as the initial symptom. The combination of arterial and venous origin of the offending vessels makes the case picturesage.
Combined hyperactive dysfunction syndrome of the cranial nerves complicated by essential hypertension: A case report.
Combined hyperactive dysfunction syndrome (HDS) refers to a special type of HDS characterized by a combination of trigeminal neuralgia (TN), hemi facial spasm (HFS), and/or gloss pharyngeal neuralgia (GPN). Rostra ventrolateral medulla (RVLM) plays a crucial role in central cardiovascular regulation, and neurovascular compression of the RVLM has been identified as a contributor to essential hypertension. A 65-year-old female with a facial tic and pain located in the root of the tongue and throat on the same side; the systolic and diastolic blood pressure was approximately 170 and 100 mmHg. The patient was diagnosed with combined HDS (HFS-GPN) and essential hypertension. Brain magnetic resonance 3-dimensional time-of-flight imaging and digital subtraction angiography revealed vertebrobasilar artery compressed the left RVLM and contacted with the root entry zones of multiple cranial nerves. The patient was treated with microvascular decompression surgery OUTCOMES:: The symptoms were completely relieved, and blood pressure was well-controlled. The pathological association of hypertension and HDS should be highlighted, and microvascular decompression is an effective approach for relieving the hypertension.
Publicações recentes
Glossopharyngeal neuralgia as initial symptom in combined hyperactive dysfunction syndrome: case report.
Combined hyperactive dysfunction syndrome of the cranial nerves complicated by essential hypertension: A case report.
Combined Hyperactive Dysfunction Syndrome of the Cranial Nerves: Analysis of 37 Cases and Literature Review.
Microvascular Decompression of the Optic Nerve for Paroxysmal Phosphenes and Visual Field Deficit.
[Painful tic convulsif and Botulinum toxin].
📚 EuropePMC5 artigos no totalmostrando 8
Comparison of Prognosis After Microvascular Decompression in Combined and Single Hyperactive Dysfunction Syndrome of the Cranial Nerves.
World neurosurgeryConcomitant trigeminal and glossopharyngeal neuralgia: Illustrative case and scoping review.
Surgical neurology internationalA New Form of Combined Hyperactive Dysfunction Syndrome: A Unique Case.
CureusGlossopharyngeal neuralgia as initial symptom in combined hyperactive dysfunction syndrome: case report.
British journal of neurosurgeryCombined hyperactive dysfunction syndrome of the cranial nerves complicated by essential hypertension: A case report.
MedicineCombined Hyperactive Dysfunction Syndrome of the Cranial Nerves: Analysis of 37 Cases and Literature Review.
World neurosurgeryCombined Hyperactive Dysfunction Syndrome of the Cranial Nerves: A Retrospective Systematic Study of Clinical Characteristics in 44 Patients.
World neurosurgeryMicrovascular Decompression of the Optic Nerve for Paroxysmal Phosphenes and Visual Field Deficit.
World neurosurgeryAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Síndrome de disfunção combinada hiperativa dos nervos cranianos.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Síndrome de disfunção combinada hiperativa dos nervos cranianos
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Ainda não achamos doenças com sintomas parecidos o suficiente.
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Concomitant trigeminal and glossopharyngeal neuralgia: Illustrative case and scoping review.
- Comparison of Prognosis After Microvascular Decompression in Combined and Single Hyperactive Dysfunction Syndrome of the Cranial Nerves.
- A New Form of Combined Hyperactive Dysfunction Syndrome: A Unique Case.
- Glossopharyngeal neuralgia as initial symptom in combined hyperactive dysfunction syndrome: case report.
- Combined hyperactive dysfunction syndrome of the cranial nerves complicated by essential hypertension: A case report.
- Combined Hyperactive Dysfunction Syndrome of the Cranial Nerves: Analysis of 37 Cases and Literature Review.
- Microvascular Decompression of the Optic Nerve for Paroxysmal Phosphenes and Visual Field Deficit.
- [Painful tic convulsif and Botulinum toxin].
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:221078(Orphanet)
- MONDO:0016371(MONDO)
- GARD:20541(GARD (NIH))
- Busca completa no PubMed(PubMed)
- Q55786175(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar